Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gojotv!on Jun 28, 2021 2:03pm
154 Views
Post# 33460411

RE:RE:I saw this with PYR... a20-plus bagger...

RE:RE:I saw this with PYR... a20-plus bagger...We all know that bashers will LIE until their teeth fall out, so let's deal with "Liked2Bash"'s gaslighting point-by-point...

Liked2Think wrote: There has been no proof of "a steady stream of sales"
thats a lie


If there hasn't been a steady stream of sales, how did revenues remain so steady in the last couple of quarters? Revenues are generated by sales. When Lied2Sink calls me a liar, he is clearly projecting.

Liked2Think wrote:
a $5 stock?  are you high?  We are a 47 cent stock, well probably lower than that after tomorrow
another lie


Hello, stupid. I'm talking about PYR in my post. They haven't been able to reach higher because they don't have the steady stream of sales that SZLS has... They are essentially a $5 stock (a 15- bagger over its original $0.35 price) which has been pumped on no news, repeated promise, and falling sales. Meanwhile, SZLS has all the elements that PYR lacks.

Liked2Think wrote:
next financials will be eye opening?  how so?  Even this new info Nails posted said the guy estimates Q3 will be the first sales of Airistotle.


*facepalm!
Care Oncology's deployment of Aristotle doesn't count as "sales", does it? Tripp said that Aristotle testing had begun. If you can't make sense of what people are telling you, investing may not be your bag.


Liked2Think wrote:
you have been saying massive things coming for next financials
total lie


The total lie is that I ever said such a thing. I said that financials would be indicative and maybe even have some surprises. "Massive" is your fabrication. You, Lied2Sink, are a pro basher who lies the way a dog poos. Regularly, and without an afterthought. And now, let's all take a moment to witness the splendid carpet of lies you weave...
Considering you are here every day, and haven't sold your shares, it's clear even you don't believe your own drivel.... And how easily you ignore the $17Million U.S. sales projections in the next six months...!!
GLTA longs who are paying attention!
Rewards go to the smart folks with the steely nerves, lol.


Liked2Think wrote:
Face it Q2 will produce only some covid revenue. (hopefully still in the 2 million range although I predict 1.7-1.8 instead, signing off on the health clinics, and thats it.  They have no new news and no more revenue from aristotle testing for Q2.

Everyone chewed me out when I said the april disaster pushed this company back a year.

So if this guy says Q3 they start to get into Aristotle then we will see those beginning results Oct 15. So then you would assume Q4 would be a bit better than Q3 and we see those results Jan 15 2022.  By the time next April comes around covid testing could be non existant by then.  All depends on what happens the next winter.  If Aristotle isnt making at least 2-3 million every quarter by then then you might as well put a pin in this company cause its done and aristotle will just be another colonsentry.  A superior product that no one cares about and their is no demand for.  Just like the 1,000 tests per day covid capacity that only had 500 a day in demand at the peak.


<< Previous
Bullboard Posts
Next >>